Amplity Health’s Post

Yes! We are seeing more and more Payors and IDNs going it alone to help with the patient stickiness factor and to help improve existing marketplace customer service failures. Sometimes when you want the best for members and patients, you need to do it yourself. D2 has helped many IDNs, Independent Pharmacy Organizations/co-ops, and Payors build solutions that truly improve patient outcomes, lower healthcare costs, improve margins, and enhance the patient experiece... It can be done. It is being done. Many stakeholders are seeking new solutions.

𝗥𝗲𝗺𝗮𝗿𝗸𝗮𝗯𝗹𝗲 𝗰𝗵𝗮𝗻𝗴𝗲 𝗶𝘀 𝘂𝗽𝗼𝗻 𝘂𝘀. 𝗪𝗵𝗲𝗻 𝗱𝗶𝗱 𝘆𝗼𝘂 𝗹𝗮𝘀𝘁 𝗵𝗲𝗮𝗿 𝗮𝗯𝗼𝘂𝘁 𝗮 𝗠𝗥 (𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗥𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝘃𝗲) 𝗿𝗼𝗹𝗲 𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗶𝗻 𝘁𝗵𝗲 𝗜𝗻𝗱𝗶𝗮𝗻 𝗣𝗵𝗮𝗿𝗺𝗮 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆? Transforming from mere product promoters, MRs are now grouping into specialities. Equipping themselves with profound knowledge, they now provide in-depth disease insights, treatment options, the pinnacle of patient care.👨⚕️💡 In a digitised world, their platforms have shifted from offline meetings to online discussions with doctors. Their understanding broadening towards the extensive healthcare system rather than being confined to the brand they represent.💻🌐 Their focus has diverged from product promotion to delivering personalized solutions, meeting patient's unique needs. Thus inculcating “patients first” motto rather than “product first”. 🎯👥 Let's discuss! Do you think the new role of MR's is having an impact on patient care? Or is it simply opening new channels for Pharma promotions? Your experience and insights are welcome! 🗣� #MRTransformation #PharmaIndustryEvolution #MedicalRepresentativeSpecialization #HealthcareInsights #PatientCare #DigitizationInPharma #PersonalizedSolutions #PatientsFirstMotto #Healthcare

Life sciences organizations are increasingly challenged with demonstrating the benefit their medicines bring to customers across the healthcare ecosystem. In this on-demand webinar, Mark Rodgers, our AVP of Commercial Analytics, shares strategies and tools to meaningfully engage with customers above the brand, identify opportunities to improve health outcomes, and demonstrate differentiated value. Watch it here: https://ow.ly/pEV230sF2wl #CommercialInsights #RealworldData #LifeSciences

I just finished watching a fantastic webinar put on by True Rx Health Strategists with Mark Cuban. Here are a few key insights/takeaways: -Pharmacy benefits are overly complex and not a #ceo 's core competency (their business is). -Publicly traded PBM's don't offer ANYTHING that the middle-market solutions can't and they hold data hostage and/or charge you for it! -RFP's need to include Mark Cuban Cost Plus Drug Company, PBC and a list of PBM's that are integrated with them that can pass-through the full value of their pricing. -PATIENTS and their families need to be front and center, not misaligned profit as costs go up and "rebate loans" -Even if a CEO "gets it" #hr is often terrified of the conversion and associated disruption. -Independent pharmacies are getting squeezed out of business which removes critical care access points, especially in rural communities. We started Granite Peak Analytics, LLC almost 5 years ago to shine a light on ALL of this. We now have an ambassador with a huge platform along with entrepreneurial disruptors doing things different (and better). PRO TIP: Just asking for a list of PBM's to be included in the RFP along with Cost Plus Drugs is a starting point. Ensuring that whoever is running the RFP can ACCURATELY and in an UNBIASED manner compare and contrast each option is critical. If your broker or PBM consultant is "on the take" with the incumbent Big 3, you can be certain the financial comparison will be skewed. We specialize in this. We've also done over 100 PBM conversions and know how to alleviate the fear of change and disruption. The market is shifting. A tipping point is coming. Let's go!

🎥 Watch the last in our video series on Return on Investment #ROI with Atropos Health. This final video features #AtroposHealth Chief Medical Officer and co-Founder Saurabh Gombar, MD PhD as he explains how health systems can use #RealWorldEvidence for drug cost savings and research acceleration. #AIinHealthcare #ClinicalResearch #ClinicalInformatics #DataDrivenDecisions #DataDrivenInsights #DigitalHealthcare #EvidenceBasedMedicine #FasterDecisionMaking #GenerativeAI #HealthcareInnovation #ImprovedPatientOutcomes #InnovationInHealthcare #PatientCare #realworlddata #RealWorldEvidence #ResearchAdvancements #TransformingPatientCare #HealthcareAI

Do you wonder if your peers in the industry have the same worries, struggles and fears that you do when it comes to #patientaccess? It can be hard to be that vulnerable! We have some good news! MMIT (Managed Markets Insight & Technology) just talked to over 300 of your peers - pharma execs - to learn what’s keeping them up at night—and what gets them going in the morning. Check out the findings and our expert analysis in MMIT’s first-annual State of Patient Access research report. Have questions? Want to talk about it? Let us know! https://lnkd.in/eW7JHTAE

Life sciences organizations are increasingly challenged with demonstrating the benefit their medicines bring to customers across the healthcare ecosystem. In this on-demand webinar, Mark Rodgers, our AVP of Commercial Analytics, shares strategies and tools to meaningfully engage with customers above the brand, identify opportunities to improve health outcomes, and demonstrate differentiated value. Watch it here: https://ow.ly/cVhs50S0qcR #CommercialInsights #RealworldData #LifeSciences

Life sciences organizations are increasingly challenged with demonstrating the benefit their medicines bring to customers across the healthcare ecosystem. In this on-demand webinar, Mark Rodgers, our AVP of Commercial Analytics, shares strategies and tools to meaningfully engage with customers above the brand, identify opportunities to improve health outcomes, and demonstrate differentiated value. Watch it here: https://ow.ly/cVhs50S0qcR #CommercialInsights #RealworldData #LifeSciences

Very timely and important pharmacy topic. I've seen so much change over the past 30 years in consumer habits, drug mix, pharmacy business models, technology, and network strategies, curious to hear what you think happens next Harry Travis!

Check out this video from our CMO, Saurabh Gombar, on how you can achieve #ROI in your health system using Atropos Health. Send us a message; we would love to see how we can assist you with drug cost savings and research acceleration!